Krebs Biochemicals & Industries Ltd

₹ None%

- close price

krebsbiochem.com BSE: 524518 NSE: KREBSBIO

About

Incorporated in 1991, Krebs Biochemicals & Industries Ltd is presently engaged in manufacturing of active pharmaceutical ingredients.

Key Points

Product Portfolio
a) Androstenedione which is used as Steroid Intermediate
b) Lovastatin used as Anti-cholesterol medication
c) Simvastatin is also used as Anti-cholesterol medication
d) Upcoming Products: Amlodipine, Cetirizine, Orlistat, Telmisartan, Serratiopepetidase and Phenylephrine. ^[1]

Website BSE NSE

Market Cap ₹ Cr.
Current Price ₹
High / Low ₹ /
Stock P/E
Book Value ₹
Dividend Yield %
ROCE %
ROE %
Face Value ₹

Add ratio to table

Edit ratios

Pros

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Industry:

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores




Operating Profit
OPM %

Interest
Depreciation
Profit before tax
Tax %

EPS in Rs
Raw PDF

Profit & Loss

Figures in Rs. Crores




Operating Profit
OPM %

Interest
Depreciation
Profit before tax
Tax %

EPS in Rs
Dividend Payout %

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	%
1 Year:	%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	%
Last Year:	%

Balance Sheet

Figures in Rs. Crores


Equity Capital
Reserves


Total Liabilities

CWIP
Investments

Total Assets

Cash Flows

Figures in Rs. Crores





Net Cash Flow

Ratios

Figures in Rs. Crores


Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE %

Shareholding Pattern

Numbers in percentages

	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
	72.74%	72.74%	72.72%	72.74%	72.74%	72.74%	72.74%	72.74%	72.74%	72.74%	72.74%	72.74%
	0.01%	0.01%	0.33%	0.50%	0.50%	0.50%	0.50%	0.50%	0.50%	0.50%	0.50%	0.50%
	27.25%	27.26%	26.95%	26.76%	26.77%	26.76%	26.77%	26.75%	26.75%	26.76%	26.76%	26.75%
No. of Shareholders	9,533	9,650	9,294	9,315	9,393	9,030	8,990	8,909	8,848	9,425	9,091	8,798

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	59.77%	59.77%	64.66%	67.35%	70.05%	72.74%	72.74%	72.74%	72.74%
	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.50%	0.50%	0.50%
	40.22%	40.22%	35.33%	32.64%	29.94%	27.25%	26.76%	26.75%	26.75%
No. of Shareholders	5,787	5,093	5,019	4,804	6,400	9,531	9,315	8,909	8,798

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Krebs Biochemicals & Industries Ltd

Krebs Biochemicals & Industries Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports